MP-214

DRUG2 trials

Sponsors

Tanabe Pharma Corporation

Conditions

Schizophrenia

Phase 2

A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia

CompletedNCT01625897

Tanabe Pharma CorporationSchizophrenia

Start: 2012-05-31End: 2015-03-31Updated: 2026-01-05

A Long-Term Study of MP-214 in Patients With Receiving Multiple Drugs Schizophrenia

CompletedNCT01626885

Tanabe Pharma CorporationSchizophrenia

Start: 2012-05-31End: 2014-06-30Updated: 2026-01-06